At the news
? NEUTRALIMPACT 3/10 CLUSTER filed May 19, 2026 at 16:07 ET
Two BioCryst insiders sold a total of $697K in open-market sales within a week of Q1 2026 earnings. The CLO exercised 62,500 options at $5.04 and immediately sold the shares at $9.54 for a $596K profit; a director sold 11,180 shares for $100K. The cluster value is ~0.03% of the $2.3B market cap, well below the 0.1% materiality threshold, and the CLO's sale is a routine cashless exercise pattern. The earnings filing showed in-line ORLADEYO revenue and maintained guidance, providing no bearish catalyst.
- Chief Legal Officer Barnes exercised 62,500 options at $5.04 and sold the shares at $9.54 for $596K on 2026-05-13
- Director McKee sold 11,180 shares at $8.97 for $100K on 2026-05-18
- Total insider sales of $697K represent ~0.03% of BCRX's $2.3B market cap
- Q1 2026 ORLADEYO revenue of $148.3M (+11% YoY) was in line with maintained FY2026 guidance of $625-645M
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access